Tranebjaerg–Svejgaard syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

Tranebjaerg–Svejgaard syndrome
Synonyms	X-linked hypogammaglobulinemia with isolated growth hormone deficiency
Pronounce	N/A
Specialty	N/A
Symptoms	Hypogammaglobulinemia, Growth hormone deficiency, Recurrent infections, Short stature
Complications	Infections, Growth failure
Onset	Childhood
Duration	Lifelong
Types	N/A
Causes	Genetic mutation
Risks	Family history of the condition
Diagnosis	Genetic testing, Blood test
Differential diagnosis	Common variable immunodeficiency, Isolated growth hormone deficiency
Prevention	N/A
Treatment	Immunoglobulin replacement therapy, Growth hormone therapy
Medication	Immunoglobulin, Growth hormone
Prognosis	Variable, depends on treatment
Frequency	Rare
Deaths	Not commonly reported

Tranebjaerg–Svejgaard syndrome is a rare genetic disorder characterized by a range of clinical manifestations, including hearing loss, visual impairment, and sometimes neurological issues. This syndrome is inherited in an X-linked recessive manner, meaning that the condition is often more severe in males, who have only one X chromosome, than in females, who have two X chromosomes and may therefore have a normal copy of the gene to compensate for the defective one.

Symptoms and Diagnosis

The primary symptoms of Tranebjaerg–Svejgaard syndrome include sensorineural hearing loss, which is present from birth or develops early in life, and progressive vision loss due to retinitis pigmentosa, a condition that affects the retina and causes the loss of night vision and peripheral vision. In some cases, individuals may also experience neurological symptoms such as ataxia (lack of muscle coordination), intellectual disability, and behavioral changes. Diagnosis of Tranebjaerg–Svejgaard syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the specific gene associated with the syndrome.

Genetics

The syndrome is caused by mutations in a gene located on the X chromosome. This gene is responsible for the production of a protein that plays a crucial role in the development and function of the sensory cells in the ear and the eye, as well as certain cells in the brain. Because it is an X-linked recessive disorder, females who have one mutated copy of the gene are typically carriers and may show milder symptoms, while males with one mutated copy of the gene are affected.

Management and Treatment

There is currently no cure for Tranebjaerg–Svejgaard syndrome, and treatment focuses on managing symptoms and improving quality of life. This may include the use of hearing aids for hearing loss, mobility training and assistance devices for those with vision loss, and various therapies (such as physical therapy, occupational therapy, and speech therapy) for neurological symptoms. Genetic counseling is recommended for affected individuals and their families to discuss the risk of passing the condition on to future generations.

Research

Research into Tranebjaerg–Svejgaard syndrome is ongoing, with scientists studying the genetic mechanisms behind the syndrome in hopes of developing targeted therapies. Advances in gene therapy and other genetic technologies offer hope for more effective treatments in the future.

   This article is a medical stub. You can help WikiMD by expanding it!